The diversity in peptide therapeutics is revolutionizing medicine by bridging the functional gap between small-molecule drugs and large biologics. By 2026, the peptide market is projected to reach approximately $164 billion, driven by their high specificity, low systemic toxicity, and ability to address “undruggable” targets that evade conventional therapies. The revolution in this field is […]
